Ciplox: Potent Fluoroquinolone Antibiotic for Bacterial Infections
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.46 | $43.86 (0%) | 🛒 Add to cart |
| 60 | $1.23 | $87.72 $73.96 (16%) | 🛒 Add to cart |
| 90 | $1.16 | $131.58 $104.06 (21%) | 🛒 Add to cart |
| 120 | $1.12 | $175.44 $134.16 (24%) | 🛒 Add to cart |
| 180 | $1.07 | $263.16 $193.50 (26%) | 🛒 Add to cart |
| 270 | $1.05 | $394.74 $282.94 (28%) | 🛒 Add to cart |
| 360 | $1.04
Best per pill | $526.32 $373.24 (29%) | 🛒 Add to cart |
Ciplox (ciprofloxacin) is a broad-spectrum fluoroquinolone antibiotic designed to combat a wide range of bacterial infections. As a second-generation fluoroquinolone, it demonstrates excellent tissue penetration and bactericidal activity against both Gram-positive and Gram-negative pathogens. Its mechanism of action involves inhibition of bacterial DNA gyrase and topoisomerase IV, effectively disrupting DNA replication and transcription. Clinicians frequently prescribe Ciplox for respiratory, urinary, gastrointestinal, and skin/soft tissue infections where susceptible organisms are implicated.
Features
- Contains ciprofloxacin hydrochloride as active ingredient
- Available in 250mg, 500mg, and 750mg tablet formulations
- Oral and intravenous administration options
- Rapid and complete gastrointestinal absorption
- Excellent tissue penetration characteristics
- Bactericidal activity against aerobic organisms
- Stability across various pH ranges
- Multiple international manufacturing certifications
Benefits
- Effectively eliminates susceptible bacterial pathogens through potent bactericidal action
- Provides rapid clinical improvement due to excellent bioavailability and tissue penetration
- Offers convenient twice-daily dosing regimen for improved patient compliance
- Demonstrates reliable efficacy against many antibiotic-resistant strains
- Suitable for both community-acquired and hospital-acquired infections
- Broad spectrum coverage reduces need for combination therapy in many cases
Common use
Ciplox is indicated for the treatment of adults with infections caused by susceptible strains of designated microorganisms. Common clinical applications include complicated urinary tract infections, chronic bacterial prostatitis, lower respiratory tract infections, skin and skin structure infections, bone and joint infections, infectious diarrhea, and typhoid fever. It is also used for post-exposure inhalation anthrax prophylaxis and treatment. The medication demonstrates particular effectiveness against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis, Salmonella species, Shigella species, and many Staphylococcal species.
Dosage and direction
Dosage must be adjusted based on the type and severity of infection, renal function, and patient characteristics. For most infections in adults with normal renal function, the typical dosage is 250-750 mg orally every 12 hours. The duration of therapy varies from 7 to 14 days depending on the infection type and clinical response. For urinary tract infections: 250-500 mg every 12 hours for 7-14 days. For respiratory infections: 500-750 mg every 12 hours for 7-14 days. For complicated intra-abdominal infections: 500 mg every 12 hours. Tablets should be swallowed whole with a full glass of water, and may be taken with or without food, though taking with food may reduce gastrointestinal upset. Maintain adequate hydration during treatment.
Precautions
Patients should complete the entire course of therapy even if symptoms improve. Avoid antacids containing magnesium, aluminum, calcium, or iron supplements within 2 hours before or 6 hours after taking Ciplox as they significantly reduce absorption. Use with caution in patients with central nervous system disorders, renal impairment, or history of tendon disorders. May cause dizziness or lightheadedness; patients should exercise caution when operating machinery or driving. Photosensitivity reactions may occur; appropriate sun protection measures are recommended. Monitor for signs of tendon inflammation or rupture, particularly in elderly patients and those receiving corticosteroid therapy.
Contraindications
Ciplox is contraindicated in patients with known hypersensitivity to ciprofloxacin or other quinolone antibiotics. Concomitant administration with tizanidine is contraindicated due to potentiation of hypotensive and sedative effects. Should not be used in patients with history of tendon disorders related to fluoroquinolone use. Not recommended for children and adolescents except for specific indications (complicated UTI, pyelonephritis, plague, post-exposure anthrax) where benefit outweighs risk. Avoid use in patients with known QTc prolongation or uncorrected electrolyte imbalances.
Possible side effect
Common adverse reactions (1-10% of patients) include nausea, diarrhea, vomiting, abdominal pain, headache, and restlessness. Less frequent side effects (0.1-1%) include dizziness, sleep disorders, rash, pruritus, and photosensitivity. Rare but serious adverse effects (<0.1%) include tendon rupture (particularly Achilles tendon), peripheral neuropathy, QTc prolongation, hepatic dysfunction, blood dyscrasias, and severe skin reactions. Psychiatric reactions including anxiety, depression, confusion, and hallucinations have been reported. Clostridium difficile-associated diarrhea may occur during or after treatment.
Drug interaction
Ciprofloxacin inhibits CYP1A2 enzymes and may increase concentrations of theophylline, caffeine, tizanidine, and clozapine. Concurrent use with nonsteroidal anti-inflammatory drugs may increase CNS stimulation and seizure risk. Antacids, sucralfate, iron preparations, and zinc supplements significantly reduce absorption. May enhance effects of warfarin; monitor INR closely. Concomitant use with corticosteroids may increase risk of tendon rupture. May prolong QTc interval when used with other QTc-prolonging medications. Dose adjustment may be required when administered with probenecid.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed dose. Maintain the prescribed time interval between doses to ensure consistent antibiotic levels. If multiple doses are missed, contact the prescribing physician for guidance on resuming therapy.
Overdose
In case of overdose, symptomatic and supportive care should be instituted. ECG monitoring is recommended due to potential QTc prolongation. Adequate hydration should be maintained to prevent crystal formation. Hemodialysis or peritoneal dialysis removes only small amounts (less than 10%) of ciprofloxacin. Management should include gastric lavage if presentation is early after ingestion. Specific antidote is not available. Monitor renal function and observe for signs of CNS stimulation including seizures.
Storage
Store at room temperature (15-30°C or 59-86°F) in a dry place protected from light and moisture. Keep in the original container with the lid tightly closed. Do not store in bathroom cabinets where humidity levels may fluctuate. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Properly discard any unused medication after completion of therapy.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Ciplox is a prescription medication that should only be used under the supervision of a qualified healthcare professional. The prescribing physician should be consulted for specific medical advice, diagnosis, and treatment. Individual response to medication may vary. Not all possible uses, precautions, side effects, or interactions are listed here.
Reviews
Clinical studies demonstrate ciprofloxacin efficacy rates of 85-95% for susceptible infections in compliant patients. Many clinicians report excellent results in treating complicated UTIs and respiratory infections. Some patients report rapid symptom improvement within 24-48 hours of initiation. Concerns regarding tendon toxicity and neurological side effects have led to more selective prescribing in recent years. Many infectious disease specialists reserve Ciplox for cases where benefits clearly outweigh risks and alternative antibiotics are unsuitable.